McKesson Co. (NYSE:MCK) Given Consensus Recommendation of “Moderate Buy” by Analysts

McKesson Corporation (NYSEMCK) is a multinational healthcare services and information technology company based in Irving, Texas, United States. The company operates in two segments: Healthcare Services and Information Solutions.

The Healthcare Services segment provides healthcare products and services to hospitals, health systems, long-term care facilities, and other healthcare providers. The segment includes pharmaceutical distribution, medical supplies, and equipment, as well as managed care services.

The Information Solutions segment provides information technology solutions to healthcare organizations, including electronic health records (EHR), revenue cycle management, and analytics.

As of the latest report, twelve analysts covering McKesson Corporation have given a consensus recommendation of "Moderate Buy" on the stock. This means that they believe the stock is undervalued and has potential for growth in the near future. Two analysts have rated the stock with a "Hold" recommendation, indicating that they do not see significant upside or downside potential in the stock at this time. Ten analysts have given a "Buy" recommendation to the company, indicating that they believe the stock is undervalued and has significant growth potential.

The average 12-month price objective among the analysts covering McKesson Corporation is not specified in the report. However, it is important to note that price objectives are estimates of a stock's future price based on various factors such as earnings growth, revenue growth, and market trends. These estimates can vary widely among different analysts and may not always be accurate.

Overall, the consensus recommendation of "Moderate Buy" from twelve analysts covering McKesson Corporation suggests that they believe the stock has potential for growth in the near future. However, it is important to conduct further research and consider other factors before making investment decisions.